Biotech Stock News (THLD) (BLUE) (SYN)

Threshold Pharmaceuticals (NASDAQ:THLD) On Monday December 7, 2015 shares of Threshold Pharmaceuticals fell 82% after the company announced the failure of two phase 3 clinical trials. The two phase 3 clinical trials were MAESTRO and TH-CR-406/SARC021. Each phase 3 trial was treating a different indication, but used the company’s drug Evofosfamide together with some type … Read more

Biotech Stock News (BLUE) (SNTA) (MACK) (BXLT)

Bluebird Bio (NASDAQ:BLUE)  On October 19, 2015 shares of Bluebird Bio fell approximately 4% after the company announced that one patient on its old generation gene therapy had required two blood transfusions due to anemia. One thing to keep in mind was that this patient was blood transfusion free for 7 years and that’s why … Read more

Biotech Stock News (CLDN) (BLUE) (QURE) (ONCE) (CANF) (AMGN) (MRK) (BMY)

Celladon Corporation (NASDAQ:CLDN) On April 26, 2015 Shares of Celladon Corporation tumbled 80% in one day after the company reported that its phase 2 trial using Mydicar to treat heart failure patients failed to meet on both the primary endpoint and the secondary endpoint. The phase 2 trial was known as CUPID-2 and recruited up … Read more